{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:18:14Z","timestamp":1783718294009,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijtb.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:07:19Z","timestamp":1623985639000},"page":"128-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhaled corticosteroids and risk of tuberculosis\u2014How bad is the risk?"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3839-1460","authenticated-orcid":false,"given":"Rajesh","family":"Venkitakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1499-1306","authenticated-orcid":false,"given":"Jolsana","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melcy","family":"Cleetus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2021.06.010_bib1","series-title":"Global Strategy for Asthma Management and Prevention","year":"2020"},{"key":"10.1016\/j.ijtb.2021.06.010_bib2","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2020 Report","year":"2019"},{"key":"10.1016\/j.ijtb.2021.06.010_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ijtb.2021.06.010_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.ijtb.2021.06.010_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijtb.2021.06.010_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/ijcp.12459","article-title":"Inhaled corticosteroids and the increased risk of pulmonary tuberculosis: a population-based case-control study","volume":"68","author":"Chung","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijtb.2021.06.010_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1513\/pats.200701-024FM","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease","volume":"4","author":"Suissa","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ijtb.2021.06.010_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/thoraxjnl-2012-203175","article-title":"Use of inhaled corticosteroids and the risk of tuberculosis","volume":"68","author":"Lee","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2021.06.010_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijtb.2021.06.010_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ijtb.2021.06.010_bib11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2021.06.010_bib12","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/COPD.S209273","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with obstructive lung diseases: a systematic review and meta-analysis of non-randomized studies","volume":"14","author":"Castellana","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"10.1016\/j.ijtb.2021.06.010_bib13","first-page":"971","article-title":"Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis","volume":"6","author":"Ni","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijtb.2021.06.010_bib14","doi-asserted-by":"crossref","first-page":"1700037","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijtb.2021.06.010_bib15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.12-1225","article-title":"Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD","volume":"143","author":"Kim","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2021.06.010_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Longterm use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ijtb.2021.06.010_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40265-019-01224-8","article-title":"Comparative safety profile of the fixed-dose combination corticosteroid and long-acting b 2-agonist fluticasone propionate\/formoterol fumarate: a 36- month longitudinal cohort study in UK primary care","volume":"80","author":"Price","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ijtb.2021.06.010_bib18","article-title":"Inhaled formoterol fluticasone single inhaler therapy in asthma: real-world efficacy, budget impact, and potential to improve adherence","volume":"2020","author":"Rajesh","year":"2020","journal-title":"Can Respir J J Can Thorac Soc"},{"key":"10.1016\/j.ijtb.2021.06.010_bib19","first-page":"1","article-title":"Fluticasone\/Formoterol compared with other ICS\/LABAs in asthma: a systematic review","author":"Venkitakrishnan","year":"2021","journal-title":"J Asthma"},{"key":"10.1016\/j.ijtb.2021.06.010_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12879-020-05440-6","article-title":"Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Infect Dis"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570721001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570721001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:59:25Z","timestamp":1758081565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570721001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0019570721001153"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2021.06.010","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled corticosteroids and risk of tuberculosis\u2014How bad is the risk?","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}